These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival. Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418 [TBL] [Abstract][Full Text] [Related]
5. The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma. Tanner EJ; Leitao MM; Garg K; Chi DS; Sonoda Y; Gardner GJ; Barakat RR; Jewell EL Gynecol Oncol; 2011 Dec; 123(3):548-52. PubMed ID: 21945551 [TBL] [Abstract][Full Text] [Related]
6. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer. Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232 [TBL] [Abstract][Full Text] [Related]
7. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma. Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683 [TBL] [Abstract][Full Text] [Related]
8. Prognostic parameters in carcinosarcomas of the uterus: a clinico-pathologic study. Bodner-Adler B; Bodner K; Obermair A; Czerwenka K; Petru E; Leodolter S; Mayerhofer K Anticancer Res; 2001; 21(4B):3069-74. PubMed ID: 11712812 [TBL] [Abstract][Full Text] [Related]
9. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological prognostic factors and the role of cytoreduction in surgical stage IVb endometrial cancer: a retrospective multi-institutional analysis of 248 patients in Japan. Eto T; Saito T; Kasamatsu T; Nakanishi T; Yokota H; Satoh T; Nogawa T; Yoshikawa H; Kamura T; Konishi I Gynecol Oncol; 2012 Nov; 127(2):338-44. PubMed ID: 22910693 [TBL] [Abstract][Full Text] [Related]
11. Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma. Akahira J; Tokunaga H; Toyoshima M; Takano T; Nagase S; Yoshinaga K; Tase T; Wada Y; Ito K; Niikura H; Yamada H; Sato A; Sasano H; Yaegashi N Oncology; 2006; 71(5-6):333-40. PubMed ID: 17690557 [TBL] [Abstract][Full Text] [Related]
12. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis. Nemani D; Mitra N; Guo M; Lin L Gynecol Oncol; 2008 Oct; 111(1):82-8. PubMed ID: 18674808 [TBL] [Abstract][Full Text] [Related]
13. Prophylactic pelvic irradiation as part of primary therapy in uterine sarcomas. Sorbe B; Johansson B Int J Oncol; 2008 May; 32(5):1111-7. PubMed ID: 18425339 [TBL] [Abstract][Full Text] [Related]
14. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison. Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654 [TBL] [Abstract][Full Text] [Related]
15. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573 [TBL] [Abstract][Full Text] [Related]
16. Clinical features and outcomes of uterine and ovarian carcinosarcoma. Jonson AL; Bliss RL; Truskinovsky A; Judson P; Argenta P; Carson L; Dusenbery K; Downs LS Gynecol Oncol; 2006 Mar; 100(3):561-4. PubMed ID: 16271748 [TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of 12 cases of uterine carcinosarcoma]. Wang LH; Xiong Y; Li YF; Li JD; Feng YL; Li YJ; Chen C; Chen L Ai Zheng; 2008 May; 27(5):516-9. PubMed ID: 18479602 [TBL] [Abstract][Full Text] [Related]
18. FIGO staging for carcinosarcoma: can the revised staging system predict overall survival? Pradhan TS; Stevens EE; Ablavsky M; Salame G; Lee YC; Abulafia O Gynecol Oncol; 2011 Nov; 123(2):221-4. PubMed ID: 21889193 [TBL] [Abstract][Full Text] [Related]
19. Differences in survival among patients with sarcomatoid carcinoma, carcinosarcoma and urothelial carcinoma of the bladder. Wright JL; Black PC; Brown GA; Porter MP; Kamat AM; Dinney CP; Lin DW J Urol; 2007 Dec; 178(6):2302-6; discussion 2307. PubMed ID: 17936803 [TBL] [Abstract][Full Text] [Related]
20. Carcinosarcoma of the uterus with melanocytic differentiation. Kajo K; Zubor P; Spacek J; Ryska A Pathol Res Pract; 2007; 203(10):753-8. PubMed ID: 17656038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]